{"credit":[{"email":"carl.pearson@lshtm.ac.uk","name":"Carl A. B. Pearson","typeEntity":"Person","typeRoles":[]}],"function":[{"operation":[{"term":"DNA vaccine design","uri":"http://edamontology.org/operation_0560"}]}],"labels":{"language":["R"],"topic":[{"term":"Public health and epidemiology","uri":"http://edamontology.org/topic_3305"},{"term":"Geriatric medicine","uri":"http://edamontology.org/topic_3399"},{"term":"Preclinical and clinical studies","uri":"http://edamontology.org/topic_3379"}]},"publication":[{"doi":"10.1098/RSIF.2019.0234","pmcid":"PMC6731500","pmid":"31431184"}],"summary":{"biotoolsCURIE":"biotools:denvax","biotoolsID":"denvax","description":"> LOW CONFIDENCE! | > CORRECT NAME OF TOOL COULD ALSO BE 'CYD-TDV', 'test-then-vaccinate', 'net-benefits', 'dengue' | Serostatus testing and dengue vaccine cost-benefit thresholds | R package for manuscript \"Serostatus Testing & Dengue Vaccine Cost Benefit Thresholds\"","homepage":"https://gitlab.com/cabp_LSHTM/denvax/","name":"denvax"}}